Aquestive Therapeutics Inc (AQST) — Free Cash Flow Generation Index

Latest as of March 2023: 1.00x

Aquestive Therapeutics Inc (AQST) has a Free Cash Flow Generation Index of 1.00x as of March 2023. Free cash flow of $8.81 Million represents 1% of operating cash flow ($8.82 Million). Read total liabilities of Aquestive Therapeutics Inc for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$8.81 Million
USD

Operating Cash Flow

$8.82 Million
USD

Capital Expenditures

$2.00K
USD

Aquestive Therapeutics Inc Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for Aquestive Therapeutics Inc across 1 annual periods. Explore AQST capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Aquestive Therapeutics Inc (2017–2017)

Year-by-year Free Cash Flow Generation Index for Aquestive Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Aquestive Therapeutics Inc.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2017 0.64x $3.76 Million $5.82 Million $2.07 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).